Europe Clinical Laboratory Services Market Size | Companies
The Europe clinical laboratory services market size was exhibited at USD 68.15 billion in 2023 and is projected to hit around USD 86.39 billion by 2033, growing at a CAGR of 2.4% during the forecast period 2024 to 2033.
| Report Coverage | Details |
| Market Size in 2024 | USD 69.79 Billion |
| Market Size by 2033 | USD 86.39 Billion |
| Growth Rate From 2024 to 2033 | CAGR of 2.4% |
| Base Year | 2023 |
| Forecast Period | 2024-2033 |
| Segments Covered | Test type, Service Provider, Application, Country |
| Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
| Regional Scope | Germany; UK; France; Italy; RoE |
| Key Companies Profiled | Eurofins Scientific; SYNLAB International GmbH; UNILABS; Quest Diagnostics Incorporated; Sonic Healthcare Limited; NeoGenomics Laboratories; ARUP Laboratories; Mayo Foundation for Medical Education and Research |
Market growth can be attributed to the significant increase in collaborations between European universities and clinical laboratory service providers. This trend has led to the development of cutting-edge research and innovative technologies, driving advancements in diagnostics and treatment options.
In 2023, the Europe region accounted for approximately 29.3% revenue share of the global clinical laboratory services market. The industry is driven by various initiatives undertaken by government and private organizations. These efforts aim to fund research and development in clinical laboratory tests and services, as well as promote awareness about early diagnosis.
Key government organizations, such as the European Organization for Research and Treatment of Cancer (EORTC), the European Medicines Agency (EMA), and the National Health Service (NHS), are working together to develop a comprehensive program focused on improving diagnosis in the region. For instance, the UK government has made £2.3 billion available for reform diagnostics in England, establishing over 155 Community Diagnostic Centers that have delivered over 7 million tests, checks, and scans across the country as of March 2023.
The COVID-19 pandemic has accelerated the adoption of advanced diagnostic technologies in Europe, including chemiluminescence immunoassays, real-time PCR, mass spectrometry, flow cytometry, and high-throughput assays. Countries such as Germany, Italy, the UK, and France are leading the way in implementing these cutting-edge technologies, enhancing the accuracy, efficiency, and accessibility of clinical testing, and driving market growth across the region.
Clinical chemistry tests emerged as the dominant market segment in 2023, accounting for 51.2% of the total revenue. Clinical chemistry tests are essential for primary diagnosis and laboratory testing, using techniques like spectrophotometry, immunoassay, and electrophoresis. The market is driven by innovations in chronic kidney disease, heart failure, and osteoporosis testing.
Human & tumor genetics testing is expected to experience the fastest CAGR of 6.5% over the forecast period. In countries with advanced healthcare infrastructure and a focus on precision medicine, the demand for personalized care with accurate and early diagnosis in oncology is driving growth. The adoption of next-generation sequencing and other cutting-edge diagnostic technologies is also accelerating market expansion in Europe.
In 2023, hospital-based laboratories led the service providers segment, accounting for over 50.15% of the total revenue. This dominance is expected to continue as more hospitals integrate laboratories into their facilities, driven by the increasing number of outreach programs and the high demand for timely testing and diagnosis of complex and major diseases.
Clinic-based laboratories are expected to experience a lucrative CAGR of 3.2% over the forecast period. The segment growth is driven by the increasing demand for diagnostic testing, technological advancements, and the adoption of Point-Of-Care testing. The integration of Laboratory Information Systems with electronic health records also improves workflow efficiency and data sharing, while accreditation ensures high-quality and reliable results.
Bioanalytical & lab chemistry services held the largest market share in 2023, accounting for 53.9% of the total revenue. European laboratories are harnessing the power of advanced technologies such as mass spectrometry and flow cytometry to transform clinical chemistry analysis, delivering precise, efficient, and accessible testing services. Moreover, the surge in research activities focused on genetic and proteomic studies of hereditary and gene-mutation disorders is expected to drive revenue growth for this segment over the forecast period.
The toxicology testing services segment is anticipated to exhibit the most rapid growth, with a projected CAGR of 7.6% over the forecast period. Stringent regulatory standards and a focus on product safety across industries, such as pharmaceuticals and chemicals, are key drivers. Moreover, the increasing demand for specialized toxicology testing services tailored to specific industries and applications is also contributing to the market growth.
Germany Clinical Laboratory Services Market Trends
The Germany clinical laboratory services market held the largest market share in the Europe region, accounting for 20.8% of the total revenue in 2023. This large share is attributed to the presence of many laboratories and access to innovative technologies. The country’s favorable reimbursement environment, characterized by higher prices set by manufacturers, also contributed to its market share.
The aging population, paired with the rising incidence of chronic diseases, is fueling the demand for clinical laboratory services in the UK, particularly for early and accurate disease diagnosis. A significant number of tests are conducted in the UK every year. According to the NHS, in England, over 1.12 billion pathology tests are performed every year, with private labs facing competition from low-cost NHS tests. Thus, the country has been at the forefront of investing in diagnostic testing, particularly in response to the COVID-19 pandemic.
France Clinical Laboratory Services Market Trends
The France clinical laboratory services market is expected to experience rapid growth over the forecast period, with a CAGR of 3.4% from 2024 to 2033, driven by the increasing prevalence of infectious diseases, technological advancements, and consumer awareness. The elderly population (21.7% of France’s population in 2022, as reported by the World Bank) requires more diagnostic services, making clinical laboratory services essential for accurate diagnosis and treatment.
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Nova one advisor, Inc. has segmented the Europe clinical laboratory services market
Test Type
Service Provider
Application
Country
Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles
(Upto 5 With No Cost)
Additional Countries (Apart
From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers